DECIEM detailed its integrated R&D setup at its Toronto headquarters, featuring five on-site laboratories and more than 150 in-house scientists working across preclinical discovery, delivery sciences and clinical operations. The structure supports end-to-end scientific ownership, with teams focused on mode-of-action studies, formulation delivery metrics and in vivo proof-of-concept work.
The company pairs its laboratory network with a 110,000-square-foot manufacturing hub that produces more than 250,000 units daily, alongside an ingredient audit model that vets actives across in vitro, ex vivo and in vivo testing. DECIEM also integrates social listening into its R&D process, using consumer feedback — such as insights that informed the reformulation of The Ordinary’s Hyaluronic Acid — to guide product iteration.
For consumers, the integrated model supports faster, evidence-led launches and clearer ingredient storytelling while helping maintain scientific rigor across DECIEM’s brands. The approach reflects a broader beauty trend toward transparency, substantiated claims and closer connections between consumer feedback and product development.
Image Credit: DECIEM
Why This Trend Is Growing
- Integrated Beauty R&D
- Centralized lab networks create room for faster evidence-backed formulation cycles that connect discovery, testing, manufacturing and claims substantiation under one operating model.
- Consumer-led Formulation
- Social listening and product feedback loops are reshaping skincare development by turning real-world concerns into measurable reformulation and ingredient-prioritization pathways.
- Transparent Ingredient Validation
- Multi-stage active testing across in vitro, ex vivo and in vivo settings supports more credible ingredient storytelling as consumers demand proof behind performance claims.
Industries Being Reshaped
- Skincare
- Evidence-led product pipelines are elevating competition in skincare by linking clinical rigor, delivery science and consumer education to differentiated brand trust.
- Cosmetics Manufacturing
- High-capacity production hubs paired with in-house research capabilities signal a shift toward vertically integrated beauty operations with tighter quality and speed advantages.
- Clinical Testing
- Beauty-focused clinical operations are expanding beyond compliance into strategic product development, where proof-of-concept studies and claim validation become core brand assets.
